Brief: Senti Biosciences Q4 Net Income USD -18.716 Million
Mar 21 (Reuters) - Senti Biosciences Q4 operating income USD -18.698 million. * Q4 basic EPS USD -0.42 * Q4 operating expenses USD 18.698 million * Q4 EPS USD -0.42
Recent news on Senti Biosciences Holdings
See all newsSenti Biosciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM
Brief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction